Pacira sales and marketing update

In April, Pacira will launch Exparel in the U.S. to treat post-operative pain. FDA approved the bupivacaine liposome extended-release injectable suspension using Pacira's DepoFoam drug delivery technology for the indication last year (see BioCentury, Nov. 7, 2011). ...